Imunon Inc logo

Imunon Inc

$ 1.45 +0.0101 (+0.7%) 10:08 PM EST
P/E:
At Loss
P/B:
0.25
Market Cap:
$ 10.78M
Enterprise V:
$ -20.21M
Volume:
8.90K
Avg Vol (2M):
42.09K
Also Trade In:
Volume:
8.90K
Market Cap $:
10.78M
PE Ratio:
At Loss
Avg Vol (2-Month):
42.09K
Enterprise Value $:
-20.21M
PB Ratio:
0.25
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases.
Name Current Vs Industry Vs History
Cash-To-Debt 5.87
Equity-to-Asset 0.68
Debt-to-Equity 0.15
Debt-to-EBITDA -0.28
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -8.52
Distress
Grey
Safe
Beneish M-Score -3.07
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 41.95
9-Day RSI 41.44
14-Day RSI 40.7
6-1 Month Momentum % -36.71
12-1 Month Momentum % -86.84

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.75
Quick Ratio 4.75
Cash Ratio 4.41

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -66.3

Financials (Next Earnings Date:2023-03-18 Est.)

IMNN's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:IMNN

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.5
EPS (TTM) ($) -4.272
Beta 2.05
Volatility % 58.01
14-Day RSI 40.7
14-Day ATR ($) 0.076972
20-Day SMA ($) 1.492715
12-1 Month Momentum % -86.84
52-Week Range ($) 1.3859 - 11.80494
Shares Outstanding (Mil) 7.43

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Imunon Inc Filings

Document Form Filing Date
No Filing Data

Imunon Inc Analysis

Share your research

Headlines

See More
No news.